1560 (1560) Fair Value & Analysis

Industrials · Market cap HK$73.8M

1 1560 1560 · HK

PriceHK$0.1200

Fair ValueHK$0.0980

Upside-18.3%

Quality54/100

Watch 1560 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.0535 – HK$0.1748

Fair value as of: Jul 2, 2026

From 13 valuation models · updated today

Share price −2.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0970 – HK$0.1700 · fair‑value band HK$0.0535 – HK$0.1748 · the HK$0.1200 price screens above the HK$0.0980 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1560 (1560) currently trades at HK$0.1200, while our model-based Fair Value estimate is HK$0.0980 — implying the stock looks roughly 18.3% overvalued today. We read business quality at 54/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Trailing-twelve-month revenue stands at HK$192M. Revenue declined 89.8% year over year. It earns a return on equity of -40.2%. Net debt stands at HK$1.3B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$192M

Revenue growth (YoY) -89.8%

Net margin -139%

Return on equity -40.2%

Free cash flow HK$38.7M FY2025

Operating margin -60.2%

More key figures

EPS (TTM) HK$-0.0300

EPS growth (YoY) -95.8%

Net debt HK$1.3B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1560 reported revenue of HK$215M in FY2025 versus HK$78.4M in FY2021, a compound +28.7%/yr. Reported net income was −HK$268M in FY2025.

Revenue +28.7%/yr

FY21 HK$78.4M

FY22 HK$1.7B

FY23 HK$1.2B

FY24 HK$1.1B

FY25 HK$215M

Net income

FY21 −HK$37.1M

FY22 HK$330M

FY23 −HK$295M

FY24 −HK$605M

FY25 −HK$268M

Is 1560 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Honeywell International Inc HON	C$25.91	C$14.79	-43%
CITIC Limited 0267	HK$12.87	HK$21.98	+71%
0019 0019	HK$81.70	HK$13.77	-83%
CK Hutchison Holdings 0001	HK$68.50	HK$141.53	+107%
SK Inc 034730	705,000 KRW	615,077 KRW	-13%
PT Astra International Tbk, ASII	4,730 IDR	16,231 IDR	+243%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1560 (1560) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0980 versus a price of HK$0.1200 — about −18% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1560?

Our model-based fair value for 1560 is HK$0.0980 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1200.

What is the quality score of 1560?

1560 has a Quality Score of 54/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1560 (1560)?

1560 reported trailing-twelve-month revenue of about HK$192M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1560?

The net profit margin of 1560 is about -139.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.